Kategorie: Investment Analysis

Kriya Therapeutics‘ $313M Series Funding: Decoding the Investment Thesis Behind Nine-Asset Gene Therapy Pipelines in a Challenging Market The gene therapy sector exists in a peculiar state of simultaneous crisis and opportunity. On one hand, safety concerns mount as Sarepta’s Elevidys faces scrutiny following patient deaths and the FDA restricts bluebird bio’s Skysona due to…